Immune system modeling applies dynamical systems and multi-scale approaches to understand how the immune system detects pathogens, mounts responses, and forms memory. ODE models describe the population dynamics of immune cells (T cells, B cells, antibodies) interacting with pathogens, capturing phenomena like clonal expansion, contraction, and the threshold pathogen load that triggers adaptive immunity. Agent-based models simulate individual immune cell decisions (activation, migration, differentiation, death) in tissue microenvironments. Applications include predicting vaccine efficacy, optimizing immunotherapy dosing schedules, understanding autoimmune dynamics, and modeling the within-host evolutionary dynamics of chronic infections like HIV.
The immune system is among the most complex biological systems: trillions of cells of hundreds of types, communicating through thousands of signaling molecules, distributed across every tissue, and capable of recognizing virtually any molecular structure. Modeling this system requires simplification — but the right simplifications can reveal fundamental principles that experiments alone cannot easily extract.
The most influential immune models are ODE models of within-host infection dynamics. The basic framework tracks three populations: uninfected target cells (T), infected cells (I), and free pathogen (V). Target cells become infected at a rate proportional to the product T * V (mass action), infected cells produce new pathogen and are killed (by the virus or the immune response), and pathogen is cleared. Adding an explicit immune effector cell population (E) that expands in response to antigen and kills infected cells creates a four-variable system whose dynamics capture the essential features of acute infection: exponential viral growth, immune expansion with a delay (clonal expansion takes days), viral clearance, and immune contraction after the pathogen is eliminated.
This simple model framework, when applied to HIV by Alan Perelson and David Ho, produced transformative insights. By fitting the model to patient data during antiretroviral drug treatment, they estimated that approximately 10 billion virions are produced and cleared each day — revealing that the apparently quiescent chronic phase is actually a fierce dynamic equilibrium. The high replication rate, combined with HIV's error-prone reverse transcriptase, means the virus explores a vast mutational landscape daily. Models of within-host viral evolution predicted that single-drug therapy would inevitably select for resistance, but triple-drug combinations could suppress replication below the threshold for resistance emergence. This theoretical prediction was the foundation of HAART, which transformed HIV from a death sentence to a manageable chronic condition.
Beyond infection dynamics, multi-scale immune models simulate individual cell behavior in tissue microenvironments. Agent-based models represent each T cell, dendritic cell, and pathogen as an autonomous agent with rules for migration, activation, proliferation, differentiation, and death. These models capture spatial heterogeneity (the architecture of lymph nodes, the geometry of tissue infection sites) and stochastic cell-level decisions (a naive T cell encountering a dendritic cell and deciding whether to activate based on signal strength and duration). Applications include optimizing vaccine design (which antigen formulations and adjuvants produce the strongest memory response?), predicting immunotherapy responses (what checkpoint inhibitor dose and schedule maximizes tumor killing while minimizing autoimmunity?), and understanding autoimmune dynamics (how does the balance between effector and regulatory T cells determine whether tolerance or autoimmunity prevails?). The immune system's complexity demands computational modeling — and the medical stakes ensure that these models matter.
No topics depend on this one yet.